Regeneron Pharmaceuticals shares owned by Tower Research Capital
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $10M | 9.8k | 1051.03 |
| 2024-03-31 | $8.2M | 8.5k | 962.49 |
| 2023-09-30 | $4.2M | 5.2k | 822.96 |
| 2023-06-30 | $7.9M | 11k | 718.54 |
| 2023-03-31 | $1.7M | 2.0k | 821.80 |
| 2022-12-31 | $2.6M | 3.7k | 714.29 |
| 2022-09-30 | $14M | 21k | 682.93 |
| 2022-06-30 | $11M | 19k | 591.10 |
| 2022-03-31 | $23M | 33k | 698.08 |
| 2021-12-31 | $8.9M | 14k | 631.44 |
| 2021-09-30 | $3.7M | 6.1k | 600.00 |
| 2021-06-30 | $2.7M | 4.5k | 600.00 |
| 2021-03-31 | $7.5M | 16k | 473.09 |
| 2020-12-31 | $1.6M | 3.4k | 483.02 |
| 2020-09-30 | $2.7M | 4.9k | 557.69 |
| 2020-06-30 | $2.8M | 4.5k | 623.57 |
| 2019-12-31 | $680k | 1.8k | 375.48 |
| 2019-09-30 | $413k | 1.5k | 277.18 |
| 2019-06-30 | $1.6M | 4.8k | 333.33 |
| 2019-03-31 | $767k | 1.9k | 400.00 |
| 2018-12-31 | $148k | 395 | 374.36 |
| 2018-09-30 | $785k | 1.9k | 404.01 |
| 2018-06-30 | $1.5M | 4.2k | 345.04 |
| 2017-12-31 | $110k | 286 | 384.62 |
| 2017-09-30 | $213k | 477 | 446.54 |
| 2017-03-31 | $10k | 26 | 384.62 |
| 2016-12-31 | $37k | 100 | 370.00 |
| 2016-09-30 | $0 | 1 | 0.00 |
| 2016-06-30 | $76k | 220 | 346.15 |
| 2016-03-31 | $155k | 429 | 361.31 |
| 2015-09-30 | $115k | 248 | 463.71 |
| 2015-06-30 | $362k | 710 | 509.86 |
| 2015-03-31 | $794k | 1.8k | 451.65 |
| 2014-12-31 | $14k | 35 | 400.00 |
| 2014-09-30 | $824k | 2.5k | 333.33 |
| 2014-06-30 | $25k | 90 | 277.78 |
| 2013-12-31 | $781k | 2.8k | 275.11 |
| 2013-09-30 | $296k | 946 | 313.24 |